The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Downregulation of E-selectin and contributions to immune restraining in prostate cancer.
 
Ida Deichaite
No Relationships to Disclose
 
Andrew Elliott
Employment - Caris Life Sciences
 
Ahmed Shabaik
No Relationships to Disclose
 
Leisa Sutton
No Relationships to Disclose
 
Stephanie Weaver
No Relationships to Disclose
 
Miki Haraguchi
No Relationships to Disclose
 
Daniel Geynisman
Honoraria - Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exelixis; Merck; Pfizer; Seattle Genetics/Astellas
Research Funding - Arvinas (Inst); Astellas Pharma (Inst); CG Oncology (Inst); Harpoon therapeutics (Inst); Merck (Inst)
 
Shuanzeng Wei
Consulting or Advisory Role - Caris Life Sciences
 
Napoleone Ferrara
Stock and Other Ownership Interests - Amgen; Gilead Sciences; Novartis; Roche
Patents, Royalties, Other Intellectual Property - Kalaris Therap.
 
Fotis Asimakopoulos
Stock and Other Ownership Interests - Lilly; Pfizer
Patents, Royalties, Other Intellectual Property - Stromavax
(OPTIONAL) Uncompensated Relationships - Founder Stromavax Biosciences
 
Pablo Tamayo
Research Funding - Aptose Biosystems Inc.